title: Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel.
abstract: BACKGROUND
  The incidence of classic Kaposi's sarcoma among Jews in Israel is among the highest in the developed world. Kaposi's sarcoma-associated herpesvirus (KSHV or human herpesvirus 8) is causally linked to Kaposi's sarcoma. Very little is known about the prevalence of KSHV in the Middle East or about the modes of transmission in Mediterranean countries.
  
  
  METHODS
  From 1992 through 1995, sera were obtained from 1648 adults who had tested positive for hepatitis B virus (HBV) surface antigen 20 years earlier at blood donations; sera were also obtained from 2403 of their family members. All sera were tested for anti-KSHV antibodies with the use of an indirect immunofluorescence assay. To analyze the effects of various factors on the risk of KSHV infection for both the HBV-positive cohort and their families, logistic regression for cluster data and generalized estimating equations were used. All statistical tests were two-sided.
  
  
  RESULTS
  Among family members, the seroprevalence of antibodies against KSHV was 9.9% (95% confidence interval [CI] = 8.7% to 11.1%); among the former blood donors who had tested positive for hepatitis B, it was 22% (95% CI = 19.9% to 24.1%). Overall, the best predictor of KSHV status was the place of birth. The most important risk factors found for both husband and wife to test KSHV positive were their own places of birth and their spouse's seropositivity. For a child to test positive, the most important risk factor was maternal seropositivity.
  
  
  CONCLUSIONS
  The crude prevalence rate of KSHV among the Jewish population in Israel is 9.9%. Important routes of KSHV transmission in the families studied are spouse to spouse and mother to child. The presence of KSHV in Jews in Israel of all ethnic origins and their high incidence of reported Kaposi's sarcoma suggest that KSHV was introduced into the Jewish population prior to the major Diaspora.
authors.affiliation: Epidemiology Department, Soroka University Medical Center, Ben Gurion University of the Negev, Beer-Sheva, Israel.
authors.forename: B
authors.initials: B
authors.lastname: Davidovici
authors.forename: I
authors.initials: I
authors.lastname: Karakis
authors.forename: D
authors.initials: D
authors.lastname: Bourboulia
authors.forename: S
authors.initials: S
authors.lastname: Ariad
authors.forename: J
authors.initials: J
authors.lastname: Zong
authors.forename: D
authors.initials: D
authors.lastname: Benharroch
authors.forename: N
authors.initials: N
authors.lastname: Dupin
authors.forename: R
authors.initials: R
authors.lastname: Weiss
authors.forename: G
authors.initials: G
authors.lastname: Hayward
authors.forename: B
authors.initials: B
authors.lastname: Sarov
authors.forename: C
authors.initials: C
authors.lastname: Boshoff
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D018562:Disease Transmission, Infectious; D004641:Emigration and Immigration; D005260:Female; D005814:Genes, Viral; D019288:Herpesvirus 8, Human / Q000235:genetics*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical; D007557:Israel / Q000453:epidemiology; D007585:Jews / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D017720:Molecular Epidemiology; D012111:Residence Characteristics; D012307:Risk Factors; D012514:Sarcoma, Kaposi / Q000453:epidemiology* / Q000208:ethnology; D016036:Seroepidemiologic Studies